On Sept. 23, the House Energy and Commerce Health Subcommittee held a hearing on “Examining the Increase in Drug Shortages.” Among those testifying before the Congressional panel were members of the Drug Shortage Summit Legislative and Regulatory Work Group, a group of stakeholders initially brought together in Nov. 2010 and currently functioning as an informal coalition to advance drug shortage solutions.
On Sept. 26, the FDA held a public workshop on drug shortages. ASA physicians and staff worked closely with the FDA on the program for the meeting, which included a report on the impact of drug shortages on anesthesiologists and patients.
Related Articles on Anesthesia:
74% of Michigan Residents Understand What Anesthesiologists Do
Researchers Map Molecular Pathways Used by Common Pain Drug
Dr. Michael Humphrey Discusses Draw, Downsides of Anesthesiology
